Clinical Trial Update: Sirolimus for Eosinophil-Associated Gastrointestinal Disorders [Phase 1]

View source ↗

Summary

A Phase 1 trial evaluating sirolimus for eosinophil-associated gastrointestinal disorders has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Eosinophilic Esophagitis
• Eosinophilic Gastroenteritis

Drugs mentioned

• Rapamune (sirolimus)

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: Eosinophilic Gastroenteritis, Eosinophilic Esophagitis | Phase 1 | Status: TERMINATED